{"id":949929,"date":"2026-04-08T14:06:21","date_gmt":"2026-04-08T18:06:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/"},"modified":"2026-04-08T14:06:21","modified_gmt":"2026-04-08T18:06:21","slug":"lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/","title":{"rendered":"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm"},"content":{"rendered":"
\n

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ADMA Biologics (NASDAQ: ADMA) (\u201cADMA Biologics\u201d or the \u201cCompany\u201d) for potential violations of the federal securities laws.<\/p>\n

On March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and -3% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA Biologics to book revenue and \u201creport[] growth that was never there.\u201d According to Culper Research, had ADMA Biologics not engaged in this alleged channel stuffing scheme, it would have experienced revenue declines of 3% in 2025 instead of the reported 20% growth.<\/p>\n

If you suffered a loss of more than $50,000 in ADMA Biologics securities, and wish to participate, or learn more about your eligibility, click here<\/a>, or contact our attorneys Andrea Farah (afarah@lowey.com<\/a>) at (914)733-7256 or Vincent R. Cappucci Jr. (vcappucci@lowey.com<\/a>) at (914)733-7278.<\/p>\n

\n About Lowey Dannenberg<\/strong>\n <\/p>\n

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.<\/p>\n

\n Contact<\/strong>\n <\/p>\n

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email:\u00a0 investigations@lowey.com<\/a>\u00a0<\/p>\n

\n SOURCE:<\/strong>\u00a0Lowey Dannenberg<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ADMA Biologics (NASDAQ: ADMA) (\u201cADMA Biologics\u201d or the \u201cCompany\u201d) for potential violations of the federal securities laws. On March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and -3% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA Biologics to book revenue and \u201creport[] growth that … <\/p>\n

Continue reading “Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-949929","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ADMA Biologics (NASDAQ: ADMA) (\u201cADMA Biologics\u201d or the \u201cCompany\u201d) for potential violations of the federal securities laws. On March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and -3% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA Biologics to book revenue and \u201creport[] growth that … Continue reading "Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-08T18:06:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm\",\"datePublished\":\"2026-04-08T18:06:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/\"},\"wordCount\":292,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/\",\"name\":\"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ=\",\"datePublished\":\"2026-04-08T18:06:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/","og_locale":"en_US","og_type":"article","og_title":"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk","og_description":"NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ADMA Biologics (NASDAQ: ADMA) (\u201cADMA Biologics\u201d or the \u201cCompany\u201d) for potential violations of the federal securities laws. On March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and -3% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA Biologics to book revenue and \u201creport[] growth that … Continue reading \"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-08T18:06:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm","datePublished":"2026-04-08T18:06:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/"},"wordCount":292,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/","name":"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ=","datePublished":"2026-04-08T18:06:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM1NSM3NTI1OTMwIzIxOTQ1MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-p-c-is-investigating-adma-biologics-nasdaq-adma-for-potential-violations-of-the-federal-securities-laws-and-encourages-investors-with-more-than-50000-in-losses-to-contact-the-f\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=949929"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949929\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=949929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=949929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=949929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}